Consistently, ChoKa inhibition decreased AR protein levels and AR transcriptional program, and inhibited the growth of PCa cell lines, human PCa explants, and tumor xenografts (134), suggesting ChoKa as a marker of tumor progression and a potential therapeutic target. This evidence concerns the gene AR and neoplasm.